BALFX
Price
$41.06
Change
+$0.10 (+0.24%)
Updated
Jun 2 closing price
Net Assets
278.87B
MBNAX
Price
$32.74
Change
+$0.04 (+0.12%)
Updated
Jun 2 closing price
Net Assets
444.89M
Interact to see
Advertisement

BALFX vs MBNAX

Header iconBALFX vs MBNAX Comparison
Open Charts BALFX vs MBNAXBanner chart's image
BALFX vs MBNAX Comparison Chart in %
View a ticker or compare two or three
VS
BALFX vs. MBNAX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALFX is a Hold and MBNAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALFX has more cash in the bank: 279B vs. MBNAX (445M). MBNAX pays higher dividends than BALFX: MBNAX (1.88) vs BALFX (1.75). BALFX was incepted earlier than MBNAX: BALFX (25 years) vs MBNAX (22 years). MBNAX (1.07) is less costly to investors than BALFX (0.61). MBNAX is a more actively managed with annual turnover of: 201.00 vs. BALFX (50.00). BALFX has a lower initial minimum investment than MBNAX: BALFX (250) vs MBNAX (15000). BALFX annual gain was more profitable for investors over the last year : 17.70 vs. MBNAX (8.88). BALFX return over 5 years is better than : 35.27 vs. MBNAX (-1.72).
BALFXMBNAXBALFX / MBNAX
Total Expense Ratio0.611.0558%
Annual Report Gross Expense Ratio0.611.0757%
Fund Existence25 years22 years-
Gain YTD9.6734.860199%
Front LoadN/A3%-
Min. Initial Investment250150002%
Min. Initial Investment IRAN/AN/A-
Net Assets279B445M62,697%
Annual Yield % from dividends1.751.8893%
Returns for 1 year17.708.88199%
Returns for 3 years45.4323.53193%
Returns for 5 years35.27-1.72-2,051%
Returns for 10 years85.7919.70436%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMS71.851.27
+1.80%
CMS Energy Corp
NCPL0.90N/A
+0.17%
NETCAPITAL INC.
HWKN156.65-1.24
-0.79%
Hawkins
BAER2.20-0.02
-0.90%
Bridger Aerospace Group Holdings
CTMX3.15-0.30
-8.70%
CytomX Therapeutics